Comparison of gastrointestinal landmarks using the gas-sensing capsule and wireless motility capsule.

"Declaration of personal interests: PAT: Has received support for educational conference attendance from Pfizer and Orphan Australia. CKY: Recipient of Atmo Biosciences research support. JM, FCP: None. AFC: Employee and shareholder of Atmo Biosciences. JJ: Employee and shareholder of Atmo Biosciences. REB: Consultant or advisory board member for Allergan, Atmo Biosciences, Antara. She has received speaking honoraria from Bayer. JGM: Her department financially benefits from the sales of a digital application and booklets on the FODMAP diet. DS: Previous employee of Atmo Biosciences. KKZ: Has consulted for Atmo Biosciences. RBG: Received research support from Atmo Biosciences, Zespri, Goodman Fielder, Janssen, AbbVie. He is an advisory board member for Zespri, Janssen, AbbVie and Comvita. He has received support for travel or educational planning/attendance at conferences from AbbVie, Janssen and Zespri. KJB: Employee and shareholder of Atmo Biosciences. PRG: Consultant or advisory board member for Anatara, Atmo Biosciences, Immunic Therapeutics, Novozymes, Novoviah and Comvita. He has received research grants for investigator‐driven studies from Atmo Biosciences. He holds shares in Atmo Biosciences. His Department financially benefits from the sales of a digital application, booklets and online courses on the FODMAP diet. Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians. [Correction added on 30 November 2022, after first online publication: funding statement has been added.]"

"FUNDING INFORMATION PAT is a recipient of an NHMRC postgraduate scholarship. JM is a recipient of a University of Otago Department of Medicine Scholarship. The study was supported by research grants from Atmo Biosciences. JGM is funded by the NHMRC."

"The protocol was approved by the Monash University Human Research Ethics Committee and the Northern B Health and Disability Ethics Committee prior to commencement of the study and was registered on the Australian New Zealand Clinical Trials Registry (registration number ACTRN12619001219178)."